Introduction
Salicylate and paracetamol are widely used and effective analgesic drugs which are available in the UK and much of the world without prescription. Both drugs are highly toxic when taken in overdose and the amounts which produce toxicity may be only twice the daily dose taken for chronic pain. Persons with impaired hepatic metabolism or renal insufficiency may be particularly at risk of developing severe toxicity due to their inability to metabolise and excrete the drugs efficiently.
Measurement of these two compounds in plasma gives a useful clinical index of the severity of poisoning. an indication of prognosis and the need for additional therapy. For salicylate the nomogram published by Done', and shown modified here in molar uits (Fig. I) , alIows an estimate of the peak salicylate level to be made. It relies on the fact that salicylate is excreted with zero order kinetics. For paracetamol, prognosis requires the use of a prediction graph (Fig. 2 ) which indicates the need for active treatment with a specific thiol antidote, N-acetylcysteine (NAC). 2 The requirement for these prediction graphs is due to a further similarity between these two drugs, namely the fact that in the early stages following ingestion of even a large quantity of tablets, the patient may exhibit no physical signs and experience minimal discomfort. Firm diagnosis at this stage relies almost entirely upon measurement of the plasma drug concentration, and treatment may have to be This paper was prepared at the invitation of the Analytical Methods Working Party of the Scientific Committee of the Association of Clinical Biochemists. but docs not necessarily reflect the views of the Scientific Committee. .;j ("U ri '" 0 E t-o '" 0 0 ().~...I..-;-'"T""--,r--'"T""""'-"T'"""'-"T'"""''''''-'';
(, This paper reviews currently available methods with particular emphasis on their analytical performance, and makes recommendations on appropriate methods for use in the UK in the 1980s, bearing in mind the types and costs of analytical equipment presently available in emergency laboratories.
Salicylate

CHEMISTRY
Since salicylic acid is too irritating to be taken orally, salicylates are most commonly prescribed as aspirin (acetylsalicylate). Absorption is effective by the oral or rectal route, or in the case of oil of wintergreen (methyl salicylate), via the skin. Acetylsalicylate is hydrolysed rapidly in the cells of the stomach wall and also in the liver to salicylate which passes preferentially into the more alkaline plasma. Plasma 'salicylate', therefore, is over 80% salicylic acid within 30 min of ingestion. Salicylate is 80-95% protein bound and is metabolised by a variety of routes. It is excreted both as the unchanged drug and as metabolites in the proportions shown ( Fig. 3) . The metabolites may aceumulate in plasma if renal function is compromised. In overdose it is the salicylate acid which predominates, and the half-life of elimination from the plasma is proportional to the plasma concentration, being 15 min at low therapeutic doses and up to 30 h in severe toxicity. The expected range of concentrations in plasma is 0-7 mmoVL with therapy decisions being made at concentrations between 2 and 6 mmoVL. The sensitivity required is, therefore, not high, but specificity is of great importance.
Since measurement of salicylate in plasma is used for clinical decision making, it is mandatory that only salicylate and not the more polar metabolites be measured by any method employed.
SPECIMENS
Both plasma and serum may be used for the determination of salicylate concentrations; differences between the two fluids are negligible at the concentrations usually observed during therapy or following overdose.
Quantitative analyses in urine are of little use except in detailed studies of pharmacokinetics. The screening of urine for salicylate ingestion using Trinder's reagent is, however, a useful non-invasive technique, although even therapeutic doses may give a strongly positive result.
UV METHODS
Salicylate absorbs at 236 nm with a molar extinction coefficient at this wavelength of 647 AU.
Brodie et al. 3 described a method for the determination of salicylate using UV spectro-FIG. 3. Metabolic pathways for N-acetyl salicylate and methyl salicylate. The thickness of the lines indicates the importance of the route, % excretion as salicylate and metabolites is indicated below:
(1) acetyl salicylate (aspirin). (6) acyl glucuronide (5-10%). (2) methylsalicylate.
(7) gentisic acid. (3) salicylic acid (5-10%).
(8) gentisuric acid. (4) salicyluric acid (5~%).
(9) 2,3,5, trihydroxy benzoic acid. (5) phenolic glucuronide (10-30%).
(10) 2,3 dihydroxybenzoic acid.
photometry. The method, which also measures acetylsalicylate, involved extraction of the drugs from acidified plasma and back extraction into aqueous alkali. The method was claimed to be free of interference from other common analgesics; unfortunately neither barbiturates nor paracetamol were studied. Specificity was improved by measuring"UV absorbance at pH 10·5 and pH 13; subtraction of the absorbance at pH 10·5 from the absorbance at pH 13 gives maxima at 319 and 246 with isobestic points at 300 and 268 nm."The same principle was used by Routh, who optimised the method for acetylsalicylate, which was at that time thought to be the active form, using the maximum differential absorbance at 300 nm.? This method proved unsatisfactory for salicylate but later provided an acceptable method for paracetamol once salicylate was removed:" UV methods have never gained popularity due to their non-specificity.
FLUORIMETRIC METHODS
Salicylate and acetylsalicylate fluoresce at 23~260 nm as the neutral molecules or at 400-450 nm as dipolar ions. Salicylate has been estimated f1uorimetrically as a pharmaceutical;" however, fluorescence methods in biological samples are no more sensitive than UV methods and suffer from non-specific background fluorescence. The methods measure both acetylsalicylate and salicylic acid.
COLORIMETRIC METHODS
The salicylate anion reacts with ferric nitrate to give a purple coloured complex. The reaction was introduced into clinical analysis followint he publication of a simple method by Keller. 1 ) The use of diluted plasma obviated the need for a centrifugation step and the method remained popular in paediatric laboratories, where it was necessary to use the minimum volume of plasma. The method requires only 100 !-,L plasma, and does not react with acetylsalicylate. A modification, giving enhanced precision with pH control, has been largely ignored. II Other colorimetric methods have involved dia-zotisation with 4-nitroaniline and nitrous acid. 12 use of Folin-Ciocalteau phenol reagent. 13 complexingwith cupric ion in nitrous acid!" and estimation as the nitro derivative." However. many of these assays suffer from non-specific interference as well as interference from the major metabolite. salicyluric acid and also gentisic acid.
The modified method introduced by Trinder!" which gave improved sensitivity and precision by the introduction of a protein precipitation step remains the backbone of clinical and toxicological analysis for salicylate. despite the fact that several common interferences exist (e.g.• phenothiazines). In particular. ketones also give a brownish/purple colour with salicylate. which has led to misdiagnoses in both directions between diabetic ketoacidosis and late salicylate poisoning. The ketones may be eliminated by boiling. but this is seldom mentioned in routine method sheets. Over 30 common metabolites have been noted as interfering with the ferric nitrate method'? and the survival of this methodology has been due to its simplicity. economy and widespread applicability. The only requirement is a centrifuge and a simple colorimeter. However, despite its simplicity, care is required if reproducible results are to be obtained and although the interlaboratory performance figures published by the Quality Assessment Scheme for General Clinical Chemistry (UKEQAS) indicate method coefficients of variation (CV) of < IO'Yo for most salicylate procedures, the American Association for Clinical Chemistry tdm-t quality control programme has shown CVs frequently in excess of to'Yo and on occasions in excess of 25%. This difference may be assigned in part to the fact that the UKEQAS samples are spiked only with salicylate and paracetamol whereas the AACC specimens may contain any mix of drugs at toxic concentrations. This fact highlights the weak point of the Trinder assay procedure. In particular diflunisal interferes with the Trinder method, as well as with the Abbott TDx methodology. IX The precision of the assay can be markedly improved by automation. Using a centrifugal analyser I') a CV of between 3 and 5% was obtained over the concentration range of 0·82-2·22 mmollL. The method employed a bichromatic procedure, with absorbances measured at 520 nm and 690 nm, the net absorbance, (A520-A690) being used to effectively eliminate non-specific interferences. This method has much to recommend it. but is Analytical reviews in clinical chemistry 555 perhaps inappropriate for single emergency estimations. The principle can. however. be used in a normal method. with an improvement in specificity of the method and would fit into the protocol of the newer discrete centrifugal analysers which are capable of single bichromatic analyses.
The existence of a large number of metabolic intermediates, some of which closely resemble endogenous products of metabolism, indicates that for the accurate estimation of salicylate in plasma a specific method is required. The first attempts at this employed gas liquid chromatography (GLC) and later. high performance liquid chromatography (HPLC).
CHROMATOGRAPHIC METHODS
Salicylate has been assayed by gas chromatography with flame ionisation detection?' 21 with adequate sensitivity for pharmacokinetic studies. However. the requirement for derivatisation made these procedures unattractive for routine toxicological analysis. particularly when compared with the simple colorimetric procedures available. Salicylate may be detected in a non-derivatised form using a 2·5% SE30 column. but the non-specificity of flame ionisation detectionf makes GLC a specialist procedure. Acetylsalicylate may be resolved and quantitated separately if required.
Liquid chromatography has been more widely used. Most procedures used eluants containing either phosphoric acid.23-29 nitric acid 3l ) or acetic acid,31-34 usually with methanol. but occasionally with acetonitrile as a modifier. For toxicological purposes, where sensitivity is not a problem, UV detection is adequate: a detection limit of 0·72 umol/L (0·1 ",g1mL) at 237 nm has been claimed.P Most methods also detect N-acetylsalicylate analogues and the metabolites of salicylate.f" 27. 28. 31. 35 although documentation is not always rigorous. Fluorescence does not give better sensitivity than UV. 25 As in GLC, acetyl salicylate may be resolved from salicylate.
Despite the high concentrations of salicylate found in overdose many assays still use liquidliquid extraction and subsequent concentration; dilution methods such as precipitation are. however. both simpler and faster. Acetonitrile precipitation has been used 31 while perchlorate with methanol extraction has been claimed to yield consistent recoveries.P: 28 In fact no pretreatment is strictly necessary and neat serum has been injected directly into the chromatograph. although frequent replacement of guard columns was essential. A 3 IJ.L direct injection of serum is all that is required and the method is linear up to 3·6 mmol/L, with a CV of better than 2%.
A wide variety of compounds have been used as internal standards for salicylate analyses. 8-chlorotheophylline. 23 • 2 1\ 2-methoxybenzoate. 30 • 31 3.4-dimethoxybenzoate. 24 • 37 mephenytoin." alpha phenylcinnamic acid. 33 3.4.5-trimethoxybenzaldehyde. 2K 3-methoxybenzoic acid 29 and p-toluic acid 25 have been found to be satisfactory. Douidor and Ahmed'" claimed no internal standard was necessary despite a complicated extraction procedure.
A number of reports claim no interference from common drugs. but exhaustive testing has not been carrid out. Theophylline interfered in one method-' which is a serious limitation. and important interferences were also noted in others.P" 31. 3l\ Measurement of acetylsalicylic acid may be of pharmacokinetic interest. but hydrolysis during the analysis can be a limitation in some reversed phase procedures.Fv " Procedures with the required sensitivity for meaningful pharmacokinetic studies and which allow the simultaneous determination of salicylate. its analogues and metabolites are available.P: 27. 29. 32. 39 These assays use either liquid-liquid extraction or protein precipitation procedures. Direct injection of serum with column switching and automation could be readily introduced.t" IMMUNOASSAY METHODS Immunoassay methods for salicylate have been available for some years. A radioimmunoassay (RIA) for salicylate in forensic specimens gained some popularity since the background colour of such samples was of sufficient density to give problems with colorimetry at low levels of salicylate. RIA, however. has never found a niche in routine clinical analysis where specimens of plasma are relatively free from coloured interfering compounds.
Enzyme immunoassays, and more recently. fluorimmunoassays, are available for the estimation of salicylate. They are. however. expensive relative to the colorimetric methods and require the use of equipment which is still not available in most emergency laboratories. However. due to advances in both reagents and instrumentation. optical immunoassay methods. with their inherent sensitivity and precision and known specificity are now a viable option in some laboratories.
ENZYMATIC METHODS
An enzymatic method has been reported for salicylate determination based on the oxidative decarboxylation of salicylate to catechol by the bacterial enzyme salicylate hydroxylase. obtained from Pseudomonas capacia," The reaction requires NADH or NADPH and may be monitored by observing the decrease in absorbance at 340 nm; the detection limit of the assay was stated as 0·1 mmol/L and a sample blank was required. The CV of the assay was 4% at about 1·5 mmol/L. No interference was detected from 61 commonly prescribed drugs. although metabolites of salicylate did interfere. which is of particular concern in patients with renal dysfunction.
A recent development uses the bacterial enzyme salicylate mono-oxygenase in a specific colorimetric method for sahcylate.f The method depends upon the reduction of salicylate to catechol. which is then linked to an aminophenol to yield an indophenol. The published method. which is available in kit form. is specific for salicylate and cross reacts with neither acetylsalicylate nor metabolites. It is linear over the range 0·(12-5 mmol/L and a 50 IJ.L sample with a salicylate concentration of 5 mmol/L gives an absorbance of I AU at a wavelength of 565 nm, The reaction is therefore sensitive. specific and precise (quoted CVs are of the order of 3% at levels of I mmoI/L). The method may be used manually. using a simple spectrophotometer. or may be adapted to automated analysers with an incubation time of 6 min. At present only two laboratories using this method participate in the UKEQAS circulation. It is, therefore, not possible to show definitively that the theoretical advantages of this assay are borne out in practice. CALIBRATION Salicylate and paracetamol can be purchased from reagent suppliers and standards rapidly prepared. Although metabolites cannot be readily purchased as reference materials requests to pharmaceutical companies may be treated sympathetically.
Paracetamol CHEMISTRY
Paracetamol
(acetaminophen. N-acetyl-4aminophenol) is prescribed alone or in combination with other analgesics and antihistamines. It is rapidly and completely absorbed from the gastrointestinal tract.
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Plasma concentrations peak at about 1 h folIowing ingestion, and in a patient with normal hepatic function the drug is cleared from plasma with a half-life of approximately 2 h. The effective plasma concentration for therapy is of the order of 0·65--0·130 mmoVL (10--20 mg/L). The volume of distribution is O·95±0·12 Ukg. At therapeutic concentrations paracetamol has negligible protein binding, but in overdose, where plasma concentrations exceed 1·5 mmoVL at 4 h after ingestion, up to 50% of drug may be bound. The metabolism of paracetamol is complex and is dose dependent (Fig. 4) .
At therapeutic doses 60% is conjugated with glucuronic acid and approximately 35% with sulphate. Thus 95% of paracetamol is excreted as conjugates within 24 h. The remaining 5% consists of the cysteine conjugate and smalIer amounts of hydroxylated and acetylated metabolites. Acid hydrolysis is, therefore, required if urine is to be screened for paracetamol, and this procedure also converts the freed paracetamol to 4-aminophenol alIowing simple colour tests to be carried out (see below).
In overdose, the overload on the conjugation mechanisms leads to diversion of paracetamol into an N-hydroxylation pathway which is normaIly insignificant. The product of Nhydroxylation is Nsacerylbenzoquinoneimide.P which is a highly reactive oxidising agent. In smalI quantities this is detoxified by reaction with the thiol group of glutathione to form a mercaptide, but where a large overdose has been taken, or where glutathione is depleted (e.g. in alcoholics) the N-acetylquinoneimide reacts with thiol groups in structural proteins of the hepatocyte leading to celI death and acute hepatic necrosis. This then leads to a reduced capacity for metabolism of paracetamol by the usual routes of conjugation and in the compromised liver relatively smaIl doses of paracetamol may give rise to toxicity.
FolIowing overdose, the half life of paracetamol in the plasma is increased, and this fact is used in the production of treatment nomograms, one of which is reproduced in Fig 2. The nomogram should be used with care, since P.
NH-C-CH 3
(4) r&~H2 I P.
S-CH2-CH
NH-C-CH3 OH tOOH .~ (7) Ys-glu there are several different types of units in use in the UK in 1986. (An agreement reached in 1987 as a temporary measure states that units for paracetamol should be either mglL or mmoVL.) There is an absolute requirement for the specific determination of paracetamol and the exclusion of its metabolites if the concentrations obtained are to be used in the determination of treatment. This has been well documented and a detailed comparison of method specificity has been reported.t" The major problem concerns the co-determination of metabolites, whose concentration may exceed that of the parent drug, which occurs in methods which involve an acid hydrolysis stage followed by a non-specific colour reaction.
EARLY METHODS
A method for the estimation of paracetamol in plasma was first reported in 1948 45 and a series of colorimetric and spectrophotometric methods were subsequently developed. These methods were reviewed in 1978. 46 Only a brief resume of methods up to 1978 will be given here.
Early methods were based either on the native UV absorbance of paracetamol following its extraction from plasma'" [47] [48] [49] with some specificity being achieved by using differential absorbance at pH 10 and 3, or using the indophenol reaction by coupling o-cresol to paminophenol produced from paracetamol by acid hydrolysis.50. 51 Both of these methods are unsatisfactory for the emergency estimation of paracetamol. The UV method in general givesa negative bias since extraction of paracetamol is incomplete; this is shown clearly in UKEQAS data (Fig. 5 ) and also because a large number of compounds interfere with the method, in particular non-steroidal anti-inflammatory drugs. The acid also hydrolyses paracetamol metabolites to p-aminophenol, leading to falsely high results, it does, however, form the basis for a urinary screening method.
Despite problems with acid hydrolysis and the indophenol reaction.t?: 51. 52 the simplicity and sensitivity of this approach has continued to attract analysts and methods based on nonspecific hydrolysis and coupling have continued to be published. 5 J-55 Other authors have used the Folin-Ciocalteau reagent which offers further problems of non-specificity.51" 57 The method of Chefetz et al. 511 as modified by Glynn and Kendaf" offered the first colorimetric procedure with improved specificity. The method. based on protein precipitation. followed by nitration of paracetamol to 2-nitro-4-acetamidophcnol. allows the quantitation of paracctamol in the presence of its metabolites. The reaction although theoretically general for phenols and phenolic ethers. is in fact modified so as to minimise interference from phenacetin.
Monthly method means
The attraction of the method is its relative simplicity and the lack of requirement for either expensive reagents or equipment. It was therefore the method of choice in British laboratories for a decade. despite concern over interference by salicylate. Attempts to minimise this important effect resulted in several modifications. 60 . (w A much improved version of the method. based on a centrifugal analyser. requires only 50 ul. of scrurn." This method provides an economical procedure for laboratories with access to such equipment and is linear. with a coefficient of variation of 6'1.,.
Salicylate interference was negligible at a concentration of 1·45 IlmollL (200 mglL).
CHROMATOGRAPHI<' METJlODS
Since non-specificity was a continuing problem, those workers with a particular interest in paracetamol and its metabolites turned their efforts to chromatographic methods and over a period of 10 years several acceptable methods werc produced. some of which wcre optimised for the emcrgency estimation of paracctamol alone. and others for the study of the parent drug and its metabolites, Gas-liquid chromatography was first reported in 1971. 66 but the di-trirnethylsilyl derivative was found to be unstablc.t? A method for the underivatised drug'" had thc disadvantage that column efficiency declined rapidly. Forensic methods used extensive sample preparation and measurement of the benzoyl derivatives."?
For routine clinical purposes. a simplified method was reported which required only a single stage extraction into chloroform from acidified salt-saturated plasma.?" Precision was improved by the usc of an internal standard. The method was compared with the colorimetric nitration method and was found to correlate well, with a W% reduction in background for samples with paracctamol concentrations below 0·5 mmol/l.." Generally derivatisation was preferred to avoid interfcrence from barbiturates and a number of procedures were reported. t: 79 Paracetamol. being highly watcr soluble. is ideally suited to analysis by liquid chromatography. with the additional advantage that the water soluble metabolites can be estimated at Analytical reviews in clinical chemistry 559 the same time. The earliest method used ionexchange chromatography to quantitate paracctamol and six of its metabolites.t" but was chromatographically inefficient. the analysis of a single sample taking 21 h. A micromodification for clinical purposes used direct injection of serum (3 ul.), a single analysis taking 1 h. 1l1 As modern liquid chromatography developed. with improved and reliable packing materials. paracetamol and its metabolites were separated using reverse-phase chromatography'f and reverse-phase. ion-pair chromatography.P Good comparability for the parent drug in overdose was shown between GLC and HPLC for plasma samples." this procedure required 1 mL of serum and 15 min run time and was thus suitable for an emergency method. The method was subsequently modified to improve the detection of metabolitesf and further refined to allow rapid analysis on 100 ul, of plasma following both precipitation with perchloric acid and direct injection of the supernatant solution." which could be completed in less than 10 min from receipt of specimen. with a precision of ±4°!<, at a level of 0·5 mmol/L.
A large number of HPLC methods for the determination of paracetamol have been published. 1l 7 -% Some of the most recent methods describe the direct application of serum or plasma to a C18 reverse phase HPLC column." The preferred internal standards for paracetamol are N-propionyl-or N-butyryl-4-aminophenoI. Care should be taken to avoid the use of internal standards such as theophylline which may be present in clinical samples.l"
The sensitivity and selectivity of electrochemical detection has been employed in LC systems for paracetamol estimation,9')-101 although such a technique is not necessary for routine use since detection in the UV at a wavelength of2S4 nm gives more than adequate sensitivity.
Thin layer chromatography (TLC) has been used for screening for paracetamol in serum,102 but quantitative TLC has not so far gained favour as a method for drug analysis. HiTch performance TLC has been applied to saliva 03 and required chloroform extraction from acidified ammonium sulphate saturated saliva. The sensitivity limit of the method is 50 ng representing a plasma concentration of 700 nmol/L in a 2 mL specimen. Detection was by absorption at 247 nm and the precision stated as ± 12% at a concentration of 33 umol/L (5 mg/L).
The chromatographic method of choice for the determination of paracetamol with or without metabolites is reverse-phase HPLC. If there is no requirement for metabolite quantitation, then run times may be very short, «10 min).
IMMUNOASSA YS
The advent of optical immunoassay systems for the measurement of drugs, and their enthusiastic adoption by the staff of hospital laboratories for therapeutic drug monitoring has meant that equipment is available in many laboratories on which emergency analyses for paracetamol may be carried out. An enzyme immunoassay for paracetamol was introduced by the SYVA Corporation in 1983 and was found to be both accurate and precise by comparison with HPLC. I04 The assay has a lower limit of sensitivity of 0·066 mmoVL (10 mgIL) with a CV of less than 5% at concentrations above 0·133 mmol/L (20 mg/L). Metabolites, salicylate and drugs commonly coprescribed with paracetamol do not interfere. The assay has been adapted for use in 'stat' instrumentation, such as the Dupont ACA analyser and the SYVA QST system, and is applicable to a wide variety of discrete and centrifugal analysers. The sample volume required is about 50 ",L.
A fluorescence polarisation immunoassay (FPIA) is available from Abbott and despite its expense is widely used in the United States. 105 The precision and accuracy of the FPIA method on the TDx analyser are within the limits required. The method is extremely simple, requiring minimal skiIled operator assistance. It is, however, an expensive way of measuring paracetamol. In the US, FPIA and EMIT are now used by 75% of all laboratories which participate in the quality control programme provided by the American .Association for Clinical Chemistry. However, UKEQAS data indicates that in British laboratories, the most frequently used assay is the enzymatic method (see below) foIlowed by methods based on Glynn and Kendal.59
ENZYMATIC METHODS
In 1981 the development of a new enzymebased method for paracetamol was reported, based on the hydrolysis of the parent drug by a specific bacterial aryl acylamidase. IOn The full details were published in 1983. 107 This procedure allowed the sensitive and simple o-cresol colour reaction to be used following the specific hydrolysis of the parent drug. The reagents were provided in kit form and were assessed in a UK collaborative trial. Il~~This method was compared with OLe. and an HPLC method and was found to be free of interference from both major metabolites of paracetamol and by several unspecified drugs commonly taken in overdose in the UK. The range over which the methods were compared was ()-2·5 mmollL and the precision was 3·5% between batch at a level of 1·5 mmol/L. In a few cases minor discrepancies were found. in particular with frozen. highly pigmented plasma specimens such as may be found following a late-diagnosed case of paracetamol poisoning. A comparison of the method with an HPLC method and a UV spectrophotometric method revealed good correlation and no interference problems. which has been subsequently confirmed.l'"
The enzymatic method has the considerable advantage over all other methods except EMIT. that the reagents may be used in a wide variety of simple or automated analytical instruments. A modification for a centrifugal analyser has been reported'!" and others arc widely used including an in-house version reported to be extremely economical. III
Combined methodologies
Since it is advisable in all cases of possible analgesic poisoning to check for the presence of both salicylate and paracetamol, a method which would detect both drugs would seem to offer some advantages. Since both drugs chromatograph well, some authors have published HPLC methods which are capable of giving a~uantitative result for both drugs. The merhods" . 3n require only 100 ul, of sample and a relatively simple extraction procedure, which, could be further simplified or replaced by direct injection of plasma. One combined method'" did not separate paracetamol from theophylline. A further method although highly sensitive, involves a long classical extraction procedure.P These two methods cannot. therefore, be recommended for routine usc in the clinical situation.
Only chromatographic methods are currently able to simultaneously estimate the two drugs in clinical samples. Linear diode array spectrophotometry has been suggested as a method for their co-determination once extracted and back-extracted into aqueous solution, but this procedure offers no advantages over the immunoassay and enzyme linked colorimetric methods. Manufacturers are now aware of the requirementfor estimation of both analytes and one manufacturer now offers the paracetamol and salicylate enzyme reagents in a single package using a similar methodology. It would seem that these methods may well become those of choice on the basis of convenience.
Bedside testing
With the advent of rapid, specific and simple laboratory methods for both drugs, the critical path in the diagnostic procedure has now become the transfer of specimens and results between ward and laboratory. There has long been a feeling that these assays should be available at the bedside in the emergency ward. 112 The Trindcr method for salicylate is still used at the bedside in some units but paracetamol estimations have remained laboratory-based. An attempt was made in 1976 to provide a ward-based assay for paracetamol based on the nitration method of Glynn and Kendal with the paracetamol concentration being placed into a broad band by comparison Analytical reviews in clinical chemistry 561 with a coloured glass reference screen, along the lines of a Lovibond comparator. lI 3-115 The method was imprecise and the use of hazardous liquid reagents in a ward setting was inappropriate!" with the result that the method did not gain general acceptance.
Since that time, the development of dry biochemistry systems such as Acculevel (SYVA) and Seralyser (AMES) for drug analyses hold out the real possibility that these assays may in the future be widely available closer to the patient. This may prove useful in casualty departments and to general practitioners and others at a distance from the laboratory enabling them to make more rapid diagnoses in cases of suspected poisoning.
Choice of methods
The analyst searching for a method of salicylate determination has many options, as HPLC, optical immunoassays and the enzymatic method all give performance which is acceptable in terms of linearity, precision and specificity. Since HPLC equipment is unlikely to be economic for emergency laboratories, serious consideration should be given to the introduction of one of the latter two techniques as the standard method for estimating salicylate in British Hospitals. Although it would appear from the UKEQAS data ( Fig. 6 ) that the Trinder method gives adequate performance it must be stressed that bovine serum spiked with salicylate is not entirely appropriate for the quality control of a method which is applied in most cases to specimens taken from cases of self-poisoning with an unknown mix of drugs and in patients who may be ketotic due to alcohol or malnutrition. The economy and simplicity of the Trinder method will mean that a move to an enzymatic or immunoassay method proceeds less rapidly than was the case for paracetamoI.
The choice of a method for the assessment of plasma paracetamol concentration depends upon whether the requirement is for a rapid. economical and widely available method for the parent drug for treatment purposes. or for a method which allows the quantitation of metabolites. if the latter is required then one of the later HPLC methods. possibly involving direct injection is the method of choice.
Since treatment of paracetamol poisoning depends upon accurate definition of the plasma paracetamol concentration. and its relation to the time of overdose. it is possible to calculate the analytical goal for this method. An imprecision of ± 10% on two analyses carried out 4 h apart in order to determine the elimination half-life of the drug. will lead. in the absence of any inaccuracies in timing. to a maximum error in half-life of ±1·3 h when the true half-life is between 2 and 4 h. This is unacceptably high and would lead to a proportion of patients being wrongly treated were accepted criteria to be applied dogmatically. For this reason. a CV of <5% is required for paracetamol estimations.
For routine emergency analysis. the choice at present is clearer than it was in 1978 and would seem to lie between enzyme immunoassay. fluorescence polarisation immunoassay or the enzymatic colorimetric method. All of these methods can give adequate precision and bias over the analytical range is also satisfactory (Fig. 5 ). It seems unlikely that any consideration other than economics or availability of compatible instrumentation will dictate a best buy between these three technologies.
